annual CFF:
-$58.30M-$19.31M(-49.53%)Summary
- As of today (June 22, 2025), ADMA annual cash flow from financing activities is -$58.30 million, with the most recent change of -$19.31 million (-49.53%) on December 31, 2024.
- During the last 3 years, ADMA annual CFF has fallen by -$179.35 million (-148.16%).
- ADMA annual CFF is now -140.52% below its all-time high of $143.90 million, reached on December 31, 2020.
Performance
ADMA Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$7.13M+$23.90M(+77.03%)Summary
- As of today (June 22, 2025), ADMA quarterly cash flow from financing activities is -$7.13 million, with the most recent change of +$23.90 million (+77.03%) on March 31, 2025.
- Over the past year, ADMA quarterly CFF has dropped by -$5.68 million (-392.54%).
- ADMA quarterly CFF is now -107.04% below its all-time high of $101.20 million, reached on March 31, 2020.
Performance
ADMA quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$63.98M-$5.68M(-9.74%)Summary
- As of today (June 22, 2025), ADMA TTM cash flow from financing activities is -$63.98 million, with the most recent change of -$5.68 million (-9.74%) on March 31, 2025.
- Over the past year, ADMA TTM CFF has dropped by -$24.20 million (-60.82%).
- ADMA TTM CFF is now -136.14% below its all-time high of $177.03 million, reached on March 31, 2020.
Performance
ADMA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ADMA Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -49.5% | -392.5% | -60.8% |
| 3 y3 years | -148.2% | -115.1% | -150.6% |
| 5 y5 years | -172.9% | -107.0% | -136.1% |
ADMA Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -148.2% | at low | -111.4% | +81.7% | -150.6% | +3.5% |
| 5 y | 5-year | -140.5% | at low | -107.0% | +81.7% | -136.1% | +3.5% |
| alltime | all time | -140.5% | at low | -107.0% | +81.7% | -136.1% | +3.5% |
ADMA Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$7.13M(-77.0%) | -$63.98M(+9.7%) |
| Dec 2024 | -$58.30M(+49.5%) | -$31.03M(+21.8%) | -$58.30M(-12.0%) |
| Sep 2024 | - | -$25.47M(+6935.1%) | -$66.27M(+64.1%) |
| Jun 2024 | - | -$362.00K(-75.0%) | -$40.39M(+1.5%) |
| Mar 2024 | - | -$1.45M(-96.3%) | -$39.79M(+2.0%) |
| Dec 2023 | -$38.99M(-135.8%) | -$38.99M(-9473.8%) | -$38.99M(-162.1%) |
| Sep 2023 | - | $416.00K(+73.3%) | $62.75M(+2.0%) |
| Jun 2023 | - | $240.00K(-136.9%) | $61.49M(+0.9%) |
| Mar 2023 | - | -$650.00K(-101.0%) | $60.93M(-44.0%) |
| Dec 2022 | $108.85M(-10.1%) | $62.74M(-7535.8%) | $108.85M(+8.9%) |
| Sep 2022 | - | -$843.80K(+164.5%) | $99.93M(-8.3%) |
| Jun 2022 | - | -$319.00K(-100.7%) | $108.97M(-13.8%) |
| Mar 2022 | - | $47.27M(-12.2%) | $126.47M(+4.5%) |
| Dec 2021 | $121.05M(-15.9%) | $53.82M(+556.1%) | $121.05M(+21.9%) |
| Sep 2021 | - | $8.20M(-52.3%) | $99.29M(-2.4%) |
| Jun 2021 | - | $17.18M(-58.9%) | $101.72M(+20.3%) |
| Mar 2021 | - | $41.84M(+30.5%) | $84.54M(-41.3%) |
| Dec 2020 | $143.90M(+79.9%) | $32.06M(+201.6%) | $143.90M(+28.7%) |
| Sep 2020 | - | $10.63M(<-9900.0%) | $111.83M(+10.5%) |
| Jun 2020 | - | -$1700.00(-100.0%) | $101.19M(-42.8%) |
| Mar 2020 | - | $101.20M(<-9900.0%) | $177.03M(+121.3%) |
| Dec 2019 | $80.00M(+86.4%) | -$7700.00(+1.3%) | $80.00M(-0.0%) |
| Sep 2019 | - | -$7600.00(-100.0%) | $80.01M(+0.0%) |
| Jun 2019 | - | $75.84M(+1715.6%) | $80.00M(+69.9%) |
| Mar 2019 | - | $4.18M(<-9900.0%) | $47.10M(+9.7%) |
| Dec 2018 | $42.92M(-29.3%) | -$500.00(-96.1%) | $42.92M(-54.0%) |
| Sep 2018 | - | -$12.90K(-100.0%) | $93.30M(+1.8%) |
| Jun 2018 | - | $42.94M(<-9900.0%) | $91.65M(+48.1%) |
| Mar 2018 | - | -$4400.00(-100.0%) | $61.86M(+1.8%) |
| Dec 2017 | $60.75M | $50.37M(-3128.6%) | $60.75M(+485.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$1.66M(-112.6%) | $10.37M(-12.4%) |
| Jun 2017 | - | $13.15M(-1279.7%) | $11.84M(-24.7%) |
| Mar 2017 | - | -$1.12M(>+9900.0%) | $15.73M(-6.6%) |
| Dec 2016 | $16.84M(+61.9%) | -$3900.00(-98.0%) | $16.84M(+0.3%) |
| Sep 2016 | - | -$198.90K(-101.2%) | $16.78M(-0.4%) |
| Jun 2016 | - | $17.04M(<-9900.0%) | $16.85M(<-9900.0%) |
| Mar 2016 | - | -$3700.00(-93.8%) | -$61.40K(-100.6%) |
| Dec 2015 | $10.40M(+6.2%) | -$59.30K(-53.7%) | $10.40M(-32.9%) |
| Sep 2015 | - | -$128.10K(-198.8%) | $15.50M(-0.5%) |
| Jun 2015 | - | $129.70K(-98.8%) | $15.58M(+0.7%) |
| Mar 2015 | - | $10.46M(+107.6%) | $15.47M(+57.9%) |
| Dec 2014 | $9.80M(-64.6%) | $5.04M(<-9900.0%) | $9.80M(-68.8%) |
| Sep 2014 | - | -$49.10K(-399.4%) | $31.43M(-0.1%) |
| Jun 2014 | - | $16.40K(-99.7%) | $31.44M(-0.2%) |
| Mar 2014 | - | $4.79M(-82.0%) | $31.50M(+14.0%) |
| Dec 2013 | $27.63M(+41.9%) | $26.67M(<-9900.0%) | $27.63M(+498.0%) |
| Sep 2013 | - | -$31.40K(-145.7%) | $4.62M(+0.2%) |
| Jun 2013 | - | $68.70K(-92.6%) | $4.61M(+8.7%) |
| Mar 2013 | - | $925.70K(-74.7%) | $4.25M(-78.2%) |
| Dec 2012 | $19.47M(>+9900.0%) | $3.66M(-9527.1%) | $19.47M(+23.0%) |
| Sep 2012 | - | -$38.80K(-87.0%) | $15.83M(-0.3%) |
| Jun 2012 | - | -$299.00K(-101.9%) | $15.87M(-1.8%) |
| Mar 2012 | - | $16.15M(>+9900.0%) | $16.17M(>+9900.0%) |
| Dec 2011 | - | $15.00K(+476.9%) | $34.60K(+23.1%) |
| Sep 2011 | - | $2600.00(>+9900.0%) | $28.10K(+10.2%) |
| Jun 2011 | $25.50K(+10.9%) | $0.00(-100.0%) | $25.50K(0.0%) |
| Mar 2011 | - | $17.00K(+100.0%) | $25.50K(+200.0%) |
| Dec 2010 | - | $8500.00(>+9900.0%) | $8500.00(>+9900.0%) |
| Sep 2010 | - | $0.00 | $0.00 |
| Jun 2010 | $23.00K | - | - |
FAQ
- What is ADMA Biologics annual cash flow from financing activities?
- What is the all time high annual CFF for ADMA Biologics?
- What is ADMA Biologics annual CFF year-on-year change?
- What is ADMA Biologics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ADMA Biologics?
- What is ADMA Biologics quarterly CFF year-on-year change?
- What is ADMA Biologics TTM cash flow from financing activities?
- What is the all time high TTM CFF for ADMA Biologics?
- What is ADMA Biologics TTM CFF year-on-year change?
What is ADMA Biologics annual cash flow from financing activities?
The current annual CFF of ADMA is -$58.30M
What is the all time high annual CFF for ADMA Biologics?
ADMA Biologics all-time high annual cash flow from financing activities is $143.90M
What is ADMA Biologics annual CFF year-on-year change?
Over the past year, ADMA annual cash flow from financing activities has changed by -$19.31M (-49.53%)
What is ADMA Biologics quarterly cash flow from financing activities?
The current quarterly CFF of ADMA is -$7.13M
What is the all time high quarterly CFF for ADMA Biologics?
ADMA Biologics all-time high quarterly cash flow from financing activities is $101.20M
What is ADMA Biologics quarterly CFF year-on-year change?
Over the past year, ADMA quarterly cash flow from financing activities has changed by -$5.68M (-392.54%)
What is ADMA Biologics TTM cash flow from financing activities?
The current TTM CFF of ADMA is -$63.98M
What is the all time high TTM CFF for ADMA Biologics?
ADMA Biologics all-time high TTM cash flow from financing activities is $177.03M
What is ADMA Biologics TTM CFF year-on-year change?
Over the past year, ADMA TTM cash flow from financing activities has changed by -$24.20M (-60.82%)